Paratek Pharma Inc (PRTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,283 | 80,492 | 111,124 | 75,423 | 103,874 |
| Marketable Securities | 30,020 | 15,107 | N/A | N/A | N/A |
| Receivables | 28,259 | 33,117 | 22,132 | 60,809 | 18,538 |
| Inventories | 12,732 | 11,020 | 8,824 | 7,954 | 14,207 |
| TOTAL | $133,282 | $152,100 | $153,011 | $153,504 | $141,831 |
| Non-Current Assets | |||||
| PPE Net | 762 | 794 | 872 | 965 | 970 |
| Intangibles | 829 | 829 | 829 | 829 | 829 |
| Other Non-Current Assets | 35,284 | 30,146 | 27,636 | 24,290 | 15,647 |
| TOTAL | $36,875 | $31,769 | $29,337 | $26,084 | $17,446 |
| Total Assets | $170,157 | $183,869 | $182,348 | $179,588 | $159,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,697 | 5,394 | 4,991 | 2,590 | 4,045 |
| Accrued Expenses | 22,133 | 23,446 | 23,164 | 17,361 | 17,630 |
| Other current liabilities | 2,007 | 2,457 | 995 | 1,026 | 1,282 |
| TOTAL | $28,837 | $31,297 | $29,150 | $20,977 | $22,957 |
| Non-Current Liabilities | |||||
| Long Term Debt | 255,949 | 254,428 | 253,269 | 252,759 | 250,809 |
| Other Non-Current Liabilities | 25,673 | 25,931 | 4,922 | 5,143 | 4,519 |
| TOTAL | $281,622 | $280,359 | $258,191 | $257,902 | $255,328 |
| Total Liabilities | $310,459 | $311,656 | $287,341 | $278,879 | $278,285 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,479 | 52,366 | 50,189 | 48,795 | 46,928 |
| Common Shares | 53 | 52 | 50 | 48 | 47 |
| Retained earnings | -884,793 | -866,883 | -834,630 | -816,428 | -826,145 |
| Other shareholders' equity | -180 | -9 | 0 | 0 | 0 |
| TOTAL | $-140,302 | $-127,787 | $-104,993 | $-99,291 | $-119,008 |
| Total Liabilities And Equity | $170,157 | $183,869 | $182,348 | $179,588 | $159,277 |